The latest trading session saw Kyndryl Holdings, Inc. (KD) ending at $24.33, denoting a -0.33% adjustment from its last day's close. This change lagged the S&P 500's 0.05% loss on the day. Elsewhere, ...
Bristol Myers (BMY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.